L. Benevolenskaya Et Al. , "Lumiracoxib is effective in relieving symptoms of knee or hip osteoarthritis after 4 weeks of treatment: Results from a randomized, placebo-controlled trial," Annual European Congress of Rheumatology , vol.62, Lisbon, Portugal, pp.270, 2003
Benevolenskaya, L. Et Al. 2003. Lumiracoxib is effective in relieving symptoms of knee or hip osteoarthritis after 4 weeks of treatment: Results from a randomized, placebo-controlled trial. Annual European Congress of Rheumatology , (Lisbon, Portugal), 270.
Benevolenskaya, L., Tuzun, S., Hagin, E., Moore, A., & Gimona, A., (2003). Lumiracoxib is effective in relieving symptoms of knee or hip osteoarthritis after 4 weeks of treatment: Results from a randomized, placebo-controlled trial . Annual European Congress of Rheumatology (pp.270). Lisbon, Portugal
Benevolenskaya, L Et Al. "Lumiracoxib is effective in relieving symptoms of knee or hip osteoarthritis after 4 weeks of treatment: Results from a randomized, placebo-controlled trial," Annual European Congress of Rheumatology, Lisbon, Portugal, 2003
Benevolenskaya, L Et Al. "Lumiracoxib is effective in relieving symptoms of knee or hip osteoarthritis after 4 weeks of treatment: Results from a randomized, placebo-controlled trial." Annual European Congress of Rheumatology , Lisbon, Portugal, pp.270, 2003
Benevolenskaya, L. Et Al. (2003) . "Lumiracoxib is effective in relieving symptoms of knee or hip osteoarthritis after 4 weeks of treatment: Results from a randomized, placebo-controlled trial." Annual European Congress of Rheumatology , Lisbon, Portugal, p.270.
@conferencepaper{conferencepaper, author={L Benevolenskaya Et Al. }, title={Lumiracoxib is effective in relieving symptoms of knee or hip osteoarthritis after 4 weeks of treatment: Results from a randomized, placebo-controlled trial}, congress name={Annual European Congress of Rheumatology}, city={Lisbon}, country={Portugal}, year={2003}, pages={270} }